Corrected and Republished from: “A Novel, Multiple-Antigen Pneumococcal Vaccine Protects against Lethal Streptococcus pneumoniae Challenge”

Current vaccination against Streptococcus pneumoniae uses vaccines based on capsular polysaccharides from selected serotypes and has led to nonvaccine serotype replacement disease. We have investigated an alternative serotype-independent approach, using multiple-antigen vaccines (MAV) prepared from...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Win-Yan, Entwisle, Claire, Ercoli, Giuseppe, Ramos-Sevillano, Elise, McIlgorm, Ann, Cecchini, Paola, Bailey, Christopher, Lam, Oliver, Whiting, Gail, Green, Nicola, Goldblatt, David, Wheeler, Jun X., Brown, Jeremy S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Microbial Immunity and Vaccines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9199499/
https://www.ncbi.nlm.nih.gov/pubmed/35076289
http://dx.doi.org/10.1128/IAI.00846-18a

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9199499/
https://www.ncbi.nlm.nih.gov/pubmed/35076289
http://dx.doi.org/10.1128/IAI.00846-18a

Ejemplares similares